[VTRS]
Mid
Mid
2026-08-28 18:43:11
Citizens reiterates Opus Genetics stock rating on Viatris partnership potential
Mid
2026-08-07 08:49:53
Viatris raises 2026 outlook while targeting $500M peak sales for fast-acting meloxicam
Mid
2026-08-06 20:44:10
Viatris posts Q2 beat; sells eye drug Tyrvaya to Harrow for up to $100M
Row
2026-08-06 01:03:31
Viatris Q2 preview: Analysts see profits softening amid pressure on generics business
Mid
2026-07-30 00:02:49
Viatris gains approval of Gwyn Lo contraceptive patch
1 / 2